A new generation of
nucleic-acid vaccines
Ascendra Therapeutics is a privately held, clinical-stage biopharmaceutical company headquartered in San Francisco.
Ascendra is developing off-the-shelf plasmid DNA and personalized mRNA vaccines to treat cancer and autoimmune disease. Led by a team of seasoned drug developers, oncologists and immunologists, we are building a modular platform designed for multiple tumor antigens and scalable manufacturing.
Our Mission
Vaccines that teach the immune system to fight disease
Ascendra is advancing off-the-shelf plasmid DNA and personalized mRNA vaccines designed to direct the body's own immune response against cancer and autoimmune disease.
- Modular platform — one plasmid backbone, distinct antigen constructs for each indication
- Broad reach across gastric, breast and ovarian cancer, plus autoimmune disease
- Experienced leadership spanning oncology, immunobiology and drug development
